Essential Oils Mouthrinse and Dental Floss, Comparison of Efficacy on Interproximal Gingivitis and Dental Plaque Accumulation
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
It is difficult to obtain patient's compliance with regular interproximal dental hygiene. Dental floss is recognized as an effective procedure to remove dental plaque and prevent gingivitis in the space between teeth, but it is difficult to use and most patients do no do it regularly. Essential oils mouthrinse acts on dental plaque bacteria and helps on gingivitis prevention. These properties may be of interest to control dental plaque accumulation and gingivitis in interproximal areas. The study hypothesis states that there are no differences between the use of an essential oils mouthrinse and dental floss on the reduction of dental plaque accumulation and gingivitis.
| Condition | Intervention |
|---|---|
|
Gingivitis Dental Plaque Accumulation |
Drug: Essential oils mouthrinse Device: Dental Floss |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | Comparison of Efficacy on Interproximal Gingivitis and Dental Plaque Accumulation of an Essential Oils Mouthrinse and Dental Floss. |
- Lobene Gingival Index [ Time Frame: change from baseline in gingival index at two weeks ] [ Designated as safety issue: No ]data collected at the begining of the study and two weeks after mouthrinse or dental floss use
- Saxton & Ouderaa Bleeding Index [ Time Frame: change from baseline in bleeding index at two weeks ] [ Designated as safety issue: No ]data collected at the begining of the study and two weeks after mouthrinse or dental floss use
- Quigley, Hein & Turesky Dental Plaque Index [ Time Frame: change from baseline in plaque index at two weeks ] [ Designated as safety issue: No ]data collected at the begining of the study and two weeks after mouthrinse or dental floss use
| Enrollment: | 60 |
| Study Start Date: | September 2007 |
| Study Completion Date: | September 2008 |
| Primary Completion Date: | January 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Essential oils mouthrinse
Subjects use the essential oils mouthrinse
|
Drug: Essential oils mouthrinse
Commercial mouthrinse with manufacturer's use indications
Other Name: Listerine Cool Mint
|
|
Active Comparator: Dental floss
Subjects use dental floss
|
Device: Dental Floss
Other Name: Colgate Total dental floss
|
Eligibility| Ages Eligible for Study: | 15 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- To be a student at the Dental Hygiene programme at the Lisbon Dental School
- Signature on informed consent form
- Have, at least, two quadrant with 6 teeth each
- Presence of dental plaque
Exclusion Criteria:
- Use of a mouthrinse
- Dental hygiene appointment in the past 6 months
- Use of antibiotics in the past 3 months
- Presence of extensive caries and fractures of teeth
Contacts and Locations| Portugal | |
| Faculdade de Medicina Dentária da Universidade de Lisboa | |
| Lisboa, Portugal, 1649-003 | |
| Study Director: | Mario F Bernardo, PhD | Faculdade de Medicina Dentária da Universidade de Lisboa |
More Information
Publications:
| Responsible Party: | Henrique Soares Luis, Faculdade de Medicina Dentária da Universidade de Lisboa |
| ClinicalTrials.gov Identifier: | NCT01236963 History of Changes |
| Other Study ID Numbers: | 9/2006b |
| Study First Received: | November 8, 2010 |
| Last Updated: | November 9, 2010 |
| Health Authority: | Portugal: Health Ethic Committee |
Keywords provided by University of Lisbon:
|
Clinical trial Prevention mouthrinse Dental Floss |
Additional relevant MeSH terms:
|
Dental Plaque Gingivitis Dental Deposits Tooth Diseases |
Stomatognathic Diseases Gingival Diseases Periodontal Diseases Mouth Diseases |
ClinicalTrials.gov processed this record on May 19, 2013